Fingerprint
Dive into the research topics of 'A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
Lukas D. Wartman, Mark A. Fiala, Theresa Fletcher, Emily R. Hawkins, Amanda Cashen, John F. DIpersio, Meagan A. Jacoby, Keith E. Stockerl-Goldstein, Iskra Pusic, Geoffrey L. Uy, Peter Westervelt, Ravi Vij
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- Human Research Protection Office (HRPO)
- Section of Bone Marrow Transplant & Leukemia
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Division of Oncology
- Center of Regenerative Medicine
Research output: Contribution to journal › Letter › peer-review
15
Scopus
citations